Diabetes mellitus is a chronic disease. There are two types of this condition. Type 1 is a disease in which the patient depends on the external supply of insulin, which is injected subcutaneously. In type 2 diabetes, on the other hand, patients are not dependent on insulin. Type 1 diabetes mostly affects younger children and people who have to inject insulin for life. This fact is a burden for those affected themselves and for their relatives.
Diabetes has many secondary diseases. This includes damage to the eyes, kidneys, and blood vessels. Medical research tries to develop methods so that patients no longer must be dependent on insulin. In the past, pancreas transplantation or isolated beta cell transplantation, i.e. from insulin-producing cells in the pancreas, did not produce the desired results.
As with Alzheimer’s or myocardial infarction patients who are attempted to be treated with stem cells, there are also working groups in diabetes research that try to use regenerative medicine to regenerate the missing beta cells or to replace the beta cells with stem cell therapy. A working group consisting of scientists from Giessen, Marburg and Istanbul was appointed to explore the aforementioned therapeutic path. This means that you are in an initial phase, but it is associated with a lot of hope and can take some time. a symposium with Turkish and German scientists took place in Istanbul on February 9th, 2012.
Other research involving Diabetes focuses are autoimmunity in type 1 diabetes, insulin immunology and insulin allergy, risk genes in hypoglycemia perception, the angiogenesis of islets of Langerhans, hypertension and secondary complications in diabetes.
Contact: TDG Foundation